Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferon alfa therapy.
Geusau
A
A
University of Vienna Medical School, Austria.
Heinz-Peer
G
G
Volc-Platzer
B
B
Stingl
G
G
Kirnbauer
R
R
D000328:Adult; D001003:Anal Canal / Q000473:pathology; D001005:Anus Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D003218:Condylomata Acuminata / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D008279:Magnetic Resonance Imaging; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D010502:Perineum / Q000473:pathology; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins